Med Page Today

NOVEMBER 8, 2024

(MedPage Today) -- SAN ANTONIO -- Use of an oral biodegradable drug-free capsule led to more weight loss among patients with overweight or obesity compared with placebo, according to the randomized RESET trial. Among 279 patients, mean change.

Obesity 119

Obesity 119

Med Page Today

APRIL 18, 2024

(MedPage Today) -- Tirzepatide (Zepbound) injections reduced sleep apnea severity among patients with obesity, regardless of positive airway pressure (PAP) use, according to topline data from two phase III trials. In the SURMOUNT-OSA 1 study.

Obesity 121

Obesity 121

Cardiometabolic Health Congress

FEBRUARY 10, 2025

Obesity is a complex, chronic condition that significantly impacts cardiometabolic health and overall well-being. While management can be challenging, research-backed behavioral strategies are delivering promising results. 1 Dietary Modifications: Evidence-Based Approaches Low-Fat vs.

Obesity 52

Obesity Diet Exercise Diabetes 52

Med Page Today

NOVEMBER 26, 2024

(MedPage Today) -- Nearly half of participants in a weight-loss program who consumed alcohol at baseline began drinking less after adding an obesity drug into their weight-management regimen, a cohort study indicated. Among the 7,491 participants.

Obesity 119

Obesity 119

HCPLive

NOVEMBER 26, 2024

The investigators of this study noted an association between obesity and conditions such as rosacea, psoriasis, and lichen simplex chronicus.

Obesity 114

Obesity 114

American Heart News - Heart News

JANUARY 17, 2024

Research Highlights: Consistently high scores of perceived stress during adolescence through adulthood may contribute to worse cardiometabolic health including obesity in young adults. Researchers suggest the adoption of healthy coping strategies.

Obesity 134

Obesity Blood Pressure Diabetes Research 134

HCPLive

JANUARY 25, 2024

After adjusting for confounders, data revealed higher levels of obesity indices were linked with a gradual and dose-dependent increase in urate levels.

Obesity 115

Obesity 115

Med Page Today

JULY 5, 2024

(MedPage Today) -- GLP-1 receptor agonists lowered the risk of several obesity-associated cancers, a retrospective analysis of electronic health records suggested. Compared with insulin, GLP-1s were associated with a lower risk for developing.

Obesity 116

Obesity Cancer Diabetes 116

HCPLive

NOVEMBER 17, 2024

Obesity-related ischemic heart disease deaths rose from 1999 to 2020, particularly in middle-aged men and Black adults, per CDC WONDER data.

Obesity 111

Obesity Heart Disease 111

Journal of Clinical Investigation - Cardiology

SEPTEMBER 17, 2024

Obesity is linked to an increased risk of atrial fibrillation (AF) via increased oxidative stress. Here, we studied NOX2-mediated ROS production in obesity-mediated AF using Nox2-knockout mice and mature human induced pluripotent stem cell–derived atrial cardiomyocytes (hiPSC-aCMs).

Obesity 97

Obesity Atrial Fibrillation Diet 97

HCPLive

DECEMBER 23, 2024

Glycemic control continues to be a major risk factor for diabetic retinopathy, while overweight, obesity, and hypertension are growing in prevalence.

Risk Factors 111

Risk Factors Obesity Diabetes Hypertension 111

American Heart News - Heart News

FEBRUARY 5, 2024

Research Highlights: The weight loss medication tirzepatide significantly lowered the systolic blood pressure of nearly 500 adults who had obesity and took the medication for 36 weeks, or about eight months, in a subset of an international clinical.

Blood Pressure 128

Blood Pressure Obesity Research 128

Med Page Today

JANUARY 14, 2025

(MedPage Today) -- Medical experts from around the globe proposed a more nuanced approach to diagnosing obesity that does not rely exclusively on body mass index (BMI) alone. Writing in The Lancet Diabetes & Endocrinology, the global commission.

Obesity 108

Obesity BMI Diabetes 108

Dr. Paddy Barrett

NOVEMBER 15, 2024

A study of almost 10,000 adults with obesity (BMI >30) who were evaluated for all LE8 factors and followed for over 7 years can give us some insight 1. Many people who are overweight or obese and who cannot reduce their weight often feel that no matter what they do, they are not able to reduce their future risk. The answer is yes.

Heart Disease 98

Heart Disease Obesity Blood Pressure Cholesterol 98

HCPLive

JUNE 29, 2024

Patients with RA and obesity exhibited worse scores for subjective measures like pain and fatigue compared to those without obesity.

Obesity 98

Obesity Outcomes 98

HCPLive

SEPTEMBER 18, 2024

The new guidance reviews existing tools for weight management and provides recommendations for their use in clinical practice in patients with obesity and kidney disease.

Kidney Disease 104

Kidney Disease Obesity 104

American Heart News - Heart News

SEPTEMBER 5, 2024

Research Highlights: In an analysis of 18 randomized clinical trials, people with obesity and high blood pressure who underwent bariatric (weight-loss) surgery were almost three times more likely to achieve blood pressure remission, defined as.

Blood Pressure 113

Blood Pressure Obesity Research 113

Med Page Today

SEPTEMBER 10, 2024

(MedPage Today) -- Liraglutide (Saxenda) added to lifestyle intervention helped reduce BMI in young children with obesity, the phase IIIa SCALE Kids trial found. By week 56, kids, ages 6 to <12 years, on once-daily 3-mg liraglutide lost 5.8.

BMI 109

BMI Obesity 109

American Heart News - Heart News

NOVEMBER 11, 2024

who died from ischemic heart disease related to obesity increased by approximately 180% from 1999 to 2020. American Heart Association Scientific Sessions 2024, Abstract AC.MDP.13 13 - An analysis of data from the CDC’s WONDER database found that the number of people in the U.S.

Obesity 113

Obesity Heart Disease 113

Med Page Today

NOVEMBER 16, 2024

(MedPage Today) -- CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and accompanying heart failure with preserved ejection fraction (HFpEF), according to the SUMMIT trial. Incident.

Preserved Ejection Fraction 110

Preserved Ejection Fraction Heart Failure Obesity 110

HCPLive

FEBRUARY 5, 2024

Tirzepatide, a dual GLP-1/GIP agonist approved for diabetes and obesity, was associated with significant blood pressure reductions in an analysis of the SURMOUNT-1 trial.

Blood Pressure 116

Blood Pressure Obesity Diabetes 116

HCPLive

DECEMBER 16, 2024

Laurence Sperling, MD shares insights into a multi-disciplinary approach to the management of obesity from the perspective of a cardiologist.

Obesity 98

Obesity 98

Science Daily - Heart Disease

JANUARY 17, 2024

Young adults who reported higher stress as adolescents were more likely to have high blood pressure, obesity and other cardiometabolic risk factors as adults, finds new study.

Blood Pressure 119

Blood Pressure Obesity Risk Factors Diabetes 119

HCPLive

OCTOBER 15, 2024

Study findings showed children with both obesity and MASLD have a greater risk of youth-onset type 2 diabetes than those with obesity alone.

Obesity 98

Obesity Diabetes 98

Med Page Today

OCTOBER 2, 2024

(MedPage Today) -- The novel investigational weight loss agent HU6 had mixed results specifically targeting obesity-related heart failure with preserved ejection fraction (HFpEF), based on the small HuMain-HFpEF trial. After 19 weeks on daily.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Obesity Heart Failure 105

HCPLive

FEBRUARY 2, 2024

Obesity was linked to an increased risk of focal segmental glomerulosclerosis and hypertensive nephropathy, with further analysis revealing its impact on the risk of developing end-stage kidney disease.

Kidney Disease 105

Kidney Disease Obesity Hypertension 105

American Heart News - Heart News

NOVEMBER 16, 2024

called SUMMIT, participants with heart failure with preserved ejection fraction (HFpEF) and obesity taking tirzepatide for an average of 2 years had. Research Highlights: In an international trial of 713 adults in nine countries including the U.S.

Preserved Ejection Fraction 104

Preserved Ejection Fraction Heart Failure Obesity Research 104

Cardiovascular Diabetology

SEPTEMBER 15, 2024

Background Heart failure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovascular disease. Conclusions The findings suggest that fenofibrate may be a useful therapeutic agent for obesity- and diabetes-related cardiomyopathy.

Obesity 98

Obesity Heart Failure Diabetes Cardiomyopathy 98

Med Page Today

JANUARY 21, 2025

(MedPage Today) -- Beneficial pediatric obesity treatment response was associated with a reduced risk of obesity-related events in young adults, a nationwide prospective cohort study in Sweden showed. Compared with poor response, good response.

Obesity 93

Obesity Pediatrics Outcomes 93

Cardiometabolic Health Congress

JANUARY 3, 2024

In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.

Obesity 97

Obesity Diabetes Blood Pressure BMI 97

Becker's Hospital Review - Cardiology

NOVEMBER 13, 2024

Between 1999 and 2020, obesity-related deaths from heart disease deaths in the U.S. increased by 180%, according to a preliminary study to be presented at the American Heart Association's annual Scientific Sessions, set for Nov.

Obesity 96

Obesity Heart Disease 96

HCPLive

FEBRUARY 14, 2024

Patients with ACPA-positive RA and obesity had greater DAS44 scores compared to normal-weight patients, although this difference was not present in ACPA-negative RA.

Obesity 105

Obesity 105

Med Page Today

MAY 11, 2024

(MedPage Today) -- NEW ORLEANS -- A "culturally sensitive" exercise intervention led to weight loss and other benefits in African-American women with obesity at risk for diabetes, researchers reported. The program tested in the ongoing, single.

Obesity 94

Obesity Exercise Diabetes Research 94

Medical Xpress - Cardiology

JULY 9, 2024

Researchers from King's have identified evidence to suggest that lifestyle changes could offset the risk of some adult heart disorders that result from maternal obesity and changes in fetal heart development.

Obesity 97

Obesity Diet Exercise Research 97

Journal of Clinical Investigation - Cardiology

FEBRUARY 1, 2024

Nonalcoholic fatty liver disease (NAFLD) is prevalent in the majority of individuals with obesity, but in a subset of these individuals, it progresses to nonalcoholic steatohepatitis (0NASH) and fibrosis. The mechanisms that prevent NASH and fibrosis in the majority of patients with NAFLD remain unclear.

Obesity 106

Obesity Diet 106

Medical Xpress - Cardiology

NOVEMBER 27, 2024

The rate of deaths from ischemic heart disease related to obesity nearly tripled in the U.S. over a two-decade span, according to new research. The rate for men more than tripled.

Obesity 98

Obesity Heart Disease Research 98

HCPLive

FEBRUARY 25, 2025

A new study presented at AAAAI 2025 linked pediatric obesity to a greater risk of developing allergic rhinitis, with a 1.24x increased risk at 1 year.

Pediatrics 78

Pediatrics Obesity 78